Ascentage Pharma Group International Balance Sheet Health
Financial Health criteria checks 4/6
Ascentage Pharma Group International has a total shareholder equity of CN¥70.6M and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 2510.1%. Its total assets and total liabilities are CN¥2.5B and CN¥2.4B respectively.
Key information
2,510.1%
Debt to equity ratio
CN¥1.77b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.10b |
| Equity | CN¥70.63m |
| Total liabilities | CN¥2.43b |
| Total assets | CN¥2.50b |
Recent financial health updates
Ascentage Pharma Group International (HKG:6855) Is Making Moderate Use Of Debt
Oct 28
Ascentage Pharma Group International (HKG:6855) Is Carrying A Fair Bit Of Debt
Jun 19Ascentage Pharma Group International (HKG:6855) Has Debt But No Earnings; Should You Worry?
Dec 04Is Ascentage Pharma Group International (HKG:6855) A Risky Investment?
Aug 30Does Ascentage Pharma Group International (HKG:6855) Have A Healthy Balance Sheet?
Oct 04Recent updates
Here's Why Ascentage Pharma Group International's (HKG:6855) CEO May Not Expect A Pay Rise This Year
May 03Why We're Not Concerned Yet About Ascentage Pharma Group International's (HKG:6855) 30% Share Price Plunge
Mar 30Are Investors Undervaluing Ascentage Pharma Group International (HKG:6855) By 40%?
Feb 17There's Reason For Concern Over Ascentage Pharma Group International's (HKG:6855) Price
Dec 20Ascentage Pharma Group International (HKG:6855) Is Making Moderate Use Of Debt
Oct 28Some Analysts Just Cut Their Ascentage Pharma Group International (HKG:6855) Estimates
Aug 27There's Reason For Concern Over Ascentage Pharma Group International's (HKG:6855) Price
Aug 23Ascentage Pharma Group International (HKG:6855) Is Carrying A Fair Bit Of Debt
Jun 19Ascentage Pharma Group International (HKG:6855) Has Debt But No Earnings; Should You Worry?
Dec 04Is Ascentage Pharma Group International (HKG:6855) A Risky Investment?
Aug 30Does Ascentage Pharma Group International (HKG:6855) Have A Healthy Balance Sheet?
Oct 04An Intrinsic Calculation For Ascentage Pharma Group International (HKG:6855) Suggests It's 39% Undervalued
Jul 05The Ascentage Pharma Group International (HKG:6855) Share Price Has Gained 37% And Shareholders Are Hoping For More
Mar 01Is Ascentage Pharma Group International (HKG:6855) Popular Amongst Institutions?
Jan 26Financial Position Analysis
Short Term Liabilities: 6855's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥934.2M).
Long Term Liabilities: 6855's short term assets (CN¥1.3B) do not cover its long term liabilities (CN¥1.5B).
Debt to Equity History and Analysis
Debt Level: 6855's net debt to equity ratio (952.2%) is considered high.
Reducing Debt: 6855 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6855 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6855 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 17.1% each year.